Literature DB >> 35747765

Reversible Cytotoxic Lesion of the Corpus Callosum and COVID-19.

Jesús Garcia Castro1, Cristina Utrilla Contreras2, Ángel Martín Montes1.   

Abstract

Entities:  

Keywords:  COVID-19; corpus callosum; magnetic resonance imaging

Year:  2022        PMID： 35747765      PMCID： PMC9117954          DOI： 10.1177/19418744211039374

Source DB:  PubMed          Journal:  Neurohospitalist        ISSN： 1941-8744


× No keyword cloud information.
  6 in total

1.  Teaching NeuroImages: Cytotoxic lesions of the corpus callosum in encephalopathic patients with COVID-19.

Authors:  Myriam Edjlali; Aurélie Le Gal; Martin Louvet; Morgan Matt; Christophe Leveque; Caroline Diffre; David Orlikowski; Djillali Annane; Robert-Yves Carlier
Journal:  Neurology       Date:  2020-09-16       Impact factor: 9.910

Review 2.  Cytotoxic Lesions of the Corpus Callosum That Show Restricted Diffusion: Mechanisms, Causes, and Manifestations.

Authors:  Jay Starkey; Nobuo Kobayashi; Yuji Numaguchi; Toshio Moritani
Journal:  Radiographics       Date:  2017-02-06       Impact factor: 5.333

3.  COVID-19-Associated Cytotoxic Lesions of the Corpus Callosum.

Authors:  P Gaur; L Dixon; B Jones; H Lyall; W Jan
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-20       Impact factor: 3.825

Review 4.  Reversible lesion in the splenium of the corpus callosum.

Authors:  Syuichi Tetsuka
Journal:  Brain Behav       Date:  2019-10-06       Impact factor: 2.708

5.  Cytotoxic lesions of the corpus callosum (CLOCCs) associated with SARS-CoV-2 infection.

Authors:  Anthony Moreau; Amedee Ego; Frederic Vandergheynst; Fabio Silvio Taccone; Niloufar Sadeghi; Isabel Montesinos; Nicolas Gaspard; Julie Gorham
Journal:  J Neurol       Date:  2020-08-18       Impact factor: 4.849

Review 6.  Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts.

Authors:  Jin Wang; Mengmeng Jiang; Xin Chen; Luis J Montaner
Journal:  J Leukoc Biol       Date:  2020-06-13       Impact factor: 6.011
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.